XML 23 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net income $ 24,922 $ 33,151
Adjustments to reconcile net income (loss) to cash flow from operating activities:    
Depreciation and amortization 24,289 26,927
Amortization of deferred financing costs 1,160 2,236
Stock compensation expense 1,548 832
Net (gains) losses on sale of assets (15,873) (31,773)
(Gains) losses on extinguishment of debt 572 558
Acquisition related debt extinguishment expenses 2,781  
(Gains) losses on TSRE merger   (732)
Changes in assets and liabilities:    
Accounts receivable and other assets (1,931) (1,377)
Accounts payable and accrued expenses 8,098 3,895
Accrued interest payable (345) (376)
Other liabilities (165) (11)
Net cash provided by operating activities 45,056 33,330
Cash flows from investing activities:    
Disposition of real estate properties 34,519 39,690
Acquisition of real estate properties (169,156)  
Capital expenditures (10,100) (8,039)
(Increase) decrease in restricted cash (1,147) (2,615)
Cash flow (used in) provided by investing activities (145,884) 29,036
Cash flows from financing activities:    
Proceeds from unsecured credit facility 148,190 93,501
Unsecured credit facility repayments (138,500) (197,666)
Proceeds from mortgages   105,980
Mortgage principal repayments (1,969) (44,532)
Payments for deferred financing costs (1,166) (1,450)
Proceeds from issuance of common stock 125,707  
Distributions on common stock (37,279) (25,495)
Distributions to noncontrolling interests (1,573) (1,615)
Payments related to extinguishment of debt (2,781)  
Repurchase of shares related to equity award tax withholding (565) (143)
Cash flow provided by (used in) financing activities 90,064 (71,420)
Net change in cash and cash equivalents (10,764) (9,054)
Cash and cash equivalents, beginning of period 20,892 38,301
Cash and cash equivalents, end of the period $ 10,128 $ 29,247